Literature DB >> 7915183

Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2.

J M Withka1, D F Wyss, G Wagner, A R Arulanandam, E L Reinherz, M A Recny.   

Abstract

BACKGROUND: CD2, a T-cell specific surface glycoprotein, is critically important for mediating adherence of T cells to antigen-presenting cells or target cells. Domain 1 of human CD2 is responsible for cell adhesion, binding to CD58 (LFA-3) expressed on the cell to which the T cell binds. Human CD2 domain 1 requires N-linked carbohydrate to maintain its native conformation and ability to bind CD58. In contrast, rat CD2 does not require N-linked carbohydrate, and binds to a different ligand, CD48.
RESULTS: The three-dimensional structure of the glycosylated form of domain 1 of human CD2 has been determined by NMR spectroscopy. The overall structure resembles the typical beta-barrel of an immunoglobulin variable domain. Nuclear Overhauser enhancement contacts between the protein and the N-linked glycan have been tentatively identified.
CONCLUSION: Based on our results, we propose a model showing how the N-linked glycan might be positioned in the human CD2 domain 1 structure. The model provides an explanation for the observed instability of deglycosylated human CD2, and allows residues that are important for CD58 binding to be differentiated from those affecting conformational stability via interactions with the glycan.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7915183     DOI: 10.1016/0969-2126(93)90009-6

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  15 in total

1.  Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies.

Authors:  Z Y Sun; V Dötsch; M Kim; J Li; E L Reinherz; G Wagner
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

2.  Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation.

Authors:  Jining Liu; Jinfa Ying; Vincent T K Chow; Victor J Hruby; Seetharama D Satyanarayanajois
Journal:  J Med Chem       Date:  2005-10-06       Impact factor: 7.446

3.  The counterreceptor binding site of human CD2 exhibits an extended surface patch with multiple conformations fluctuating with millisecond to microsecond motions.

Authors:  D F Wyss; K T Dayie; G Wagner
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

4.  A feline CD2 homologue interacts with human red blood cells.

Authors:  Masayuki Shimojima; Yorihiro Nishimura; Takayuki Miyazawa; Kentaro Kato; Kazuya Nakamura; Yoshihiro Izumiya; Hiroomi Akashi; Yukinobu Tohya
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 5.  How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum.

Authors:  A Helenius
Journal:  Mol Biol Cell       Date:  1994-03       Impact factor: 4.138

6.  Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.

Authors:  Yuan Liu; Qiao Tong; Yubin Zhou; Hsiau-Wei Lee; Jenny J Yang; Hans-Jörg Bühring; Yi-Tien Chen; Binh Ha; Celia X-J Chen; Yang Yang; Ke Zen
Journal:  J Mol Biol       Date:  2006-10-03       Impact factor: 5.469

7.  Sequence specific 1H, 13C and 15N resonance assignment of rat CD2 domain 1.

Authors:  H A Chen; M Pfuhl; B Davis; P C Driscoll
Journal:  J Biomol NMR       Date:  1998-10       Impact factor: 2.835

8.  Solution structure of the potassium channel inhibitor agitoxin 2: caliper for probing channel geometry.

Authors:  A M Krezel; C Kasibhatla; P Hidalgo; R MacKinnon; G Wagner
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

9.  Sequence-specific 1H-NMR assignments and folding topology of human CD59.

Authors:  C M Fletcher; R A Harrison; P J Lachmann; D Neuhaus
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

10.  The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.

Authors:  A R Arulanandam; J M Withka; D F Wyss; G Wagner; A Kister; P Pallai; M A Recny; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.